GEODE CAPITAL MANAGEMENT, LLC - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 21 filers reported holding ELIEM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$175,952
-1.8%
66,626
+4.1%
0.00%
Q2 2023$179,239
-3.4%
64,0140.0%0.00%
Q1 2023$185,640
+80965.5%
64,0140.0%0.00%
Q4 2022$229
-99.9%
64,014
-0.2%
0.00%
Q3 2022$207,000
+7.3%
64,1390.0%0.00%
Q2 2022$193,000
-79.6%
64,139
-43.3%
0.00%
Q1 2022$948,000
-21.6%
113,021
-2.3%
0.00%
Q4 2021$1,209,000
-12.5%
115,672
+50.4%
0.00%
Q3 2021$1,382,00076,9040.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,825,134$6,698,2426.40%
RA Capital Management 13,150,849$48,263,6160.98%
SILVERARC CAPITAL MANAGEMENT, LLC 409,202$1,501,7710.43%
Atom Investors LP 75,651$277,6390.14%
DRIEHAUS CAPITAL MANAGEMENT LLC 551,942$2,025,6270.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 55,223$197,6980.01%
Chicago Partners Investment Group LLC 18,179$61,9360.00%
TUDOR INVESTMENT CORP ET AL 30,607$1120.00%
NORTHERN TRUST CORP 11,494$42,1830.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ELIEM THERAPEUTICS INC shareholders